Skip to main content
Molecure S.A. logo

Molecure S.A. — Investor Relations & Filings

Ticker · MOC ISIN · PLONCTH00011 LEI · 2594003L11V38ZCVKZ09 WAR Professional, scientific and technical activities
Filings indexed 186 across all filing types
Latest filing 2026-05-29 Board/Management Inform…
Country PL Poland
Listing WAR MOC

About Molecure S.A.

https://molecure.com/

Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drugs for diseases with high unmet medical needs. The company utilizes its expertise in medicinal chemistry and biology to identify, validate, and modulate novel protein and mRNA targets. Its therapeutic pipeline is concentrated on oncological, inflammatory, and fibrotic diseases. Molecure operates a proprietary discovery platform for targeting mRNA with small molecules, enabling the development of innovative therapies for previously untreatable conditions.

Recent filings

Filing Released Lang Actions
Zmiany w Zarządzie Spółki - Content (PL)
Board/Management Information Classification · 95% confidence The document announces that Piotr Iwanowski submitted his resignation as a Member of the Management Board effective May 29, 2026, and notes subsequent consulting arrangements. This is a direct change in senior management (a board member), fitting the Board/Management Information category.
2026-05-29 Polish
Zawiadomienie akcjonariuszy 2
Major Shareholding Notification Classification · 90% confidence The document is a Polish “zawiadomienie” under Article 69 of the Act on Public Offering, reporting changes in direct and indirect ownership levels by shareholders (Szumowski Investments and MS Galleon) following a share capital increase and related subscription agreement. It is clearly a notification of changes in significant shareholdings crossing thresholds rather than a company financial report, share issue announcement or board change. This matches the “Major Shareholding Notification” category (MRQ).
2026-05-22 Polish
Zawiadomienie akcjonariuszy 1
Major Shareholding Notification Classification · 95% confidence The document is a formal notification under Polish takeover offer law (art. 69/87) detailing direct and indirect shareholdings, percentages before and after a capital increase, and disclosing a shareholders’ tag-along agreement. This is a notification of changes in significant share ownership levels. It matches the definition of a Major Shareholding Notification (MRQ) rather than a financial report or earnings release.
2026-05-22 Polish
Otrzymanie zawiadomień, na podstawie art. 69 ust. 1 lub 2 w zw. z art. 87 ust. 1 pkt 5 ustawy o ofercie, o zbyciu akcji przez porozumienie akcjonariuszy - Content (PL)
Major Shareholding Notification Classification · 90% confidence The document is a short regulatory announcement notifying of receipt of threshold-crossing notifications under Polish securities law (Art.69/87), indicating changes in significant shareholding. It does not present financial data or a full report but formally announces major shareholding changes, matching the Major Shareholding Notification category.
2026-05-22 Polish
Tekst jednolity statutu
Governance Information Classification · 95% confidence The document is the full Statute (Articles of Association) of Molecure S.A., detailing the company’s internal rules (share capital, corporate purpose, board authorizations, governance structure). This is not an announcement of a report nor an audit, earnings release, or AGM materials. It falls squarely under internal governance documentation. Therefore, it should be classified as Governance Information (CGR).
2026-05-20 Polish
Rejestracja zmiany Statutu Spółki. - Content (PL)
Share Issue/Capital Change Classification · 88% confidence The document is an official announcement by the issuer concerning the completed increase of its share capital through the issuance of new Series K shares, registration of the related amendment to its Articles of Association, and the adoption of a new consolidated text of the Articles. It details the nominal amounts, series breakdown, and legal registration. This clearly falls under share capital changes rather than reporting financial results or other corporate actions. Therefore, it is classified as a Share Issue/Capital Change (SHA).
2026-05-20 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.